
    
      The proposed registry is a prospective, multi-center study of patients that are currently
      undergoing CryoSpray Ablation™. A maximum of 50 investigational sites will participate in
      this study.

      The study population consists of patients who are being treated with the CryoSpray Ablation™
      System for thoracic diseases. Enrolled subjects must have a signed consent form for data
      collection.
    
  